Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response

Journal of Clinical Investigation

Volumn 116, Issue 5, 2006, Pages 1243-1253

  Djalilian, Ali R ^a,b   McGaughey, David ^a,b   Patel, Satyakam ^a   Eun, Young Seo ^a   Yang, Chenghua ^a   Cheng, Jun ^a   Tomic, Melanija ^c   Sinha, Satrajit ^d   Ishida Yamamoto, Akemi ^e   Segre, Julia A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CONNEXIN 26; GAP JUNCTION PROTEIN; INVOLUCRIN; PROTEIN KLF 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EPIDERMIS; GENE EXPRESSION; IMMUNOCOMPETENT CELL; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; UPREGULATION; WOUND HEALING;

ANIMALS; ANIMALS, NEWBORN; CONNEXINS; EPIDERMIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INFLAMMATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; SKIN DISEASES; WOUND HEALING;

EID: 33646387743     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27186     Document Type: Article

References (63)

1. Segre, J.A. 2006. Epidermal barrier formation and recovery in skin disorders. J. Clin. Invest. 116:1150-1158. doi:10.1172/JCI28521.
2. Elias, P.M. 2005. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125:183-200.
3. Cartlidge, P. 2000. The epidermal barrier. Semin. Neonatol. 5:273-280.
4. Nickoloff, B.J., and Nestle, F.O. 2004. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113:1664-1675. doi:10.1172/JCI200422147.
5. Schon, M.P., and Boehncke, W.H. 2005. Psoriasis. N. Engl. J. Med. 352:1899-1912.
6. Capon, F., et al. 2001. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J. Invest. Dermatol. 116:728-730.
7. Ghadially, R., Reed, J.T., and Elias, P.M. 1996. Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol. 107:558-564.
8. Wood, L.C., Jackson, S.M., Elias, P.M., Grunfeld, C., and Feingold, K.R. 1992. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 90:482-487.
9. Proksch, E., Feingold, K.R., Man, M.Q., and Elias, P.M. 1991. Barrier function regulates epidermal DNA synthesis. J. Clin. Invest. 87:1668-1673.
10. Segre, J.A., Bauer, C., and Fuchs, E. 1999. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22:356-360.
11. Hardman, M.J., Sisi, P., Banbury, D.N., and Byrne, C. 1998. Patterned acquisition of skin barrier function during development. Development. 125:1541-1552.
12. Jaubert, J., Cheng, J., and Segre, J.A. 2003. Ectopic expression of kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development. 130:2767-2777.
13. Zhou, X., et al. 2003. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics. 13:69-78.
14. Rivas, M.V., et al. 1997. Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique. J. Invest. Dermatol. 108:188-194.
15. Kretz, M., Maass, K., and Willecke, K. 2004. Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur. J. Cell Biol. 83:647-654.
16. Stout, C., Goodenough, D.A., and Paul, D.L. 2004. Connexins: functions without junctions. Curr. Opin. Cell Biol. 16:507-512.
17. Choudhry, R., Pitts, J.D., and Hodgins, M.B. 1997. Changing patterns of gap junctional intercellular communication and connexin distribution in mouse epidermis and hair follicles during embryonic development. Dev. Dyn. 210:417-430.
18. Coutinho, P., Qiu, C., Frank, S., Tamber, K., and Becker, D. 2003. Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol. Int. 27:525-541.
19. Goliger, J.A., and Paul, D.L. 1995. Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol. Biol. Cell. 6:1491-1501.
20. Pedersen, T.X., et al. 2003. Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma. Oncogene. 22:3964-3976.
21. Labarthe, M.P., Bosco, D., Saurat, J.H., Meda, P., and Salomon, D. 1998. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J. Invest. Dermatol. 111:72-76.
22. Lucke, T., et al. 1999. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J. Invest. Dermatol. 112:354-361.
23. Kelsell, D.P. 2004. Connexin mutations in human disease. Exp. Dermatol. 13:661-662.
24. Richard, G. 2005. Connexin disorders of the skin. Clin. Dermatol. 23:23-32.
25. Iizuka, H., Takahashi, H., Honma, M., and Ishida-Yamamoto, A. 2004. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J. Dermatol. 31:271-276.
26. Martin, N., Patel, S., and Segre, J.A. 2004. Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in co-ordinate regulation. Genome Res. 14:2430-2438.
27. Patel, S., Kartasova, T., and Segre, J.A. 2003. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm. Genome. 14:140-148.
28. Koch, P.J., et al. 2000. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J. Cell Biol. 151:389-400.
29. Wakabayashi, N., et al. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35:238-245.
30. Cook, P.W., Brown, J.R., Cornell, K.A., and Pittelkow, M.R. 2004. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp. Dermatol. 13:347-356.
31. Cook, P.W., et al. 1997. Transgenic expression of the human amphiregulin gene induces a psoriasislike phenotype. J. Clin. Invest. 100:2286-2294.
32. Maass, K., et al. 2004. Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Mol. Biol. Cell. 15:4597-4608.
33. Li, E.R., Owens, D.M., Djian, P., and Watt, F.M. 2000. Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp. Dermatol. 9:431-438.
34. Eckert, R.L., et al. 2004. Regulation of involucrin gene expression. J. Invest. Dermatol. 123:13-22.
35. Jaubert, J., Patel, S., Cheng, J., and Segre, J.A. 2004. Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epidermal conditional gene expression. J. Invest. Dermatol. 123:313-318.
36. Furuse, M., et al. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 156:1099-1111.
37. Tran Van Nhieu, G., et al. 2003. Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat. Cell Biol. 5:720-726.
38. Rowland, B.D., Bernards, R., and Peeper, D.S. 2005. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7:1074-1082.
39. McDonald, O.G., Wamhoff, B.R., Hoofnagle, M.H., and Owens, G.K. 2006. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116:36-48. doi:10.1172/JCI26505.
40. Sano, S., et al. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11:43-49.
41. Georgiou, J.G., et al. 2005. Human epidermal and monocyte-derived langerhans cells express functional P2X receptors. J. Invest. Dermatol. 125:482-490.
42. Inoue, K., Denda, M., Tozaki, H., Fujishita, K., and Koizumi, S. 2005. Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes. J. Invest. Dermatol. 124:756-763.
43. Pillai, S., and Bikle, D.D. 1992. Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J. Clin. Invest. 90:42-51.
44. Denda, M., Inoue, K., Fuziwara, S., and Denda, S. 2002. P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption. J. Invest. Dermatol. 119:1034-1040.
45. Mizumoto, N., et al. 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8:358-365.
46. Granstein, R.D., et al. 2005. Augmentation of cutaneous immune re-sponses by ATPgammaS: purinergic agonists define a novel class of immunologic adjuvants. J. Immunol. 174:7725-7731.
47. Jan, A.Y., Amin, S., Ratajczak, P., Richard, G., and Sybert, V.P. 2004. Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J. Invest. Dermatol. 122:1108-1113.
48. Van Steensel, M.A., et al. 2004. A phenotype resembling the Clouston syndrome with deafness is associated with a novel missense GJB2 mutation. J. Invest. Dermatol. 123:291-293.
49. Essenfelder, G.M., et al. 2004. Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity. Hum. Mol. Genet. 13:1703-1714.
50. Li, A.G., Wang, D., Feng, X.H., and Wang, X.J. 2004. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 23:1770-1781.
51. Zenz, R., et al. 2005. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 437:369-375.
52. Soumelis, V., et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680.
53. Zhou, B., et al. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6:1047-1053.
54. Yoo, J., et al. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202:541-549.
55. Al-Shami, A., Spolski, R., Kelly, J., Keane-Myers, A., and Leonard, W.J. 2005. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202:829-839.
56. Chavanas, S., et al. 2000. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25:141-142.
57. Walley, A.J., et al. 2001. Gene polymorphism in Netherton and common atopic disease. Nat. Genet. 29:175-178.
58. Cookson, W.O., et al. 2001. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27:372-373.
59. Aszterbaum, M., Feingold, K.R., Menon, G.K., and Williams, M.L. 1993. Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat. J. Clin. Invest. 91:2703-2708.
60. Kretz, M., et al. 2003. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J. Cell Sci. 116:3443-3452.
61. Qiu, C., et al. 2003. Targeting connexin43 expression accelerates the rate of wound repair. Curr. Biol. 13:1697-1703.
62. Romano, R.A., Birkaya, B., and Sinha, S. 2006. Defining the regulatory elements in the proximal promoter of DNp63 in Keratinocytes: potential roles for Sp1/Sp3, NF-Y and p63. J. Invest. Dermatol. In press.
63. Hennings, H., et al. 1980. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell. 19:245-254.